Motif Bio plc ADRs
MTFB
MTFB was delisted on the 16th of December, 2019.
3 hedge funds and large institutions have $11.8M invested in Motif Bio plc ADRs in 2017 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
50% more funds holding
Funds holding: 2 → 3 (+1)
17% more capital invested
Capital invested by funds: $10.1M → $11.8M (+$1.72M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.03K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.98K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $11.8M | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $3K | +$3.03K | +305 | New |
|
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $2K | +$1.98K | +200 | New |
|
MTFB Hedge Fund Activity: Q4 2017 in Review
3 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc ADRs (MTFB) for Q4 2017, worth a combined $11.8M — up 17% from $10.1M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new MTFB positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $3.03K.
- 3 institutional investors held Motif Bio plc ADRs (MTFB) as of Q4 2017, up from 2 in Q3 2017.
- Funds reported $11.8M of Motif Bio plc ADRs stock for Q4 2017, up 17% quarter-over-quarter.
- 2 funds opened new Motif Bio plc ADRs positions in Q4 2017 and 1 closed out, a net change of +1 holder.
- The largest Motif Bio plc ADRs buyer in Q4 2017 was UBS Group, an estimated $3.03K added.
Based on aggregated 13F filings for Q4 2017.